2020 Year in Review: COVID-19, CRISPR and Immunotherapies Define the Year for the Life Sciences
XTalks
DECEMBER 24, 2020
Several saliva-based tests also received FDA approvals and authorizations, making sample collection easier and less invasive compared with traditional nasopharyngeal swabbing. By re-tooling it, they were able to develop CRISPR/Cas9, a precision gene editing technology that can be used in any living organism.
111 
Let's personalize your content